Company
Nanoveu Ltd
ASX:NVU
EMASS, a Nanoveu business, is a fabless semiconductor company specialising in ultra-low-power, AI-enabled system-on-chip (SoC) solutions for always-on sensing and intelligent processing at the edge. Its ECS-DoT architecture enables real-time AI inference at milliwatt-level power, supporting next-generation applications across drones, wearables, hearables, smart devices, industrial IoT, robotics and autonomous systems.
30 stories
Nanoveu skyrockets on securing Nestlé Professional as customer for Nanoshield screen protectors
The Nanoshield™ protectors are customised to fit the Nescafé touch screen and touchpad coffee machines, and will also be available for 'We Proudly Serve Starbucks®' coffee in selected markets.
Nanoveu to distribute antiviral protection products in the Philippines
The company is confident the distribution agreements will not only help in increasing its avenues to sales but also build recognition among the clients of these distributors.
Nanoveu higher as it gains further international momentum for antiviral protection technologies
The company’s antiviral technology has been independently demonstrated to be a highly effective agent for the eradication of viruses and has been proven to eliminate 99.99% of OC43, a viral strain affecting humans that is also a surrogate f
Nanoveu’s “rapid transformation” sets the scene for future growth
In 2020, the company launched an impressive new prototype that allows people suffering from farsightedness to view a 14-inch screen without glasses.
Nanoveu higher on enhancing antiviral technology with new products and outdoor testing
The Nanoshield product, launched in 2020, has been confirmed to provide exceptional antiviral protection outdoors.
Nanoveu executes 12-month exclusive UK distribution agreement with CuVira for antiviral products
The agreement, which accelerates the availability and reach of Nanoshield products across the UK, is effective immediately and incentivises sales through a series of purchase order targets.
Nanoveu executes second share subscription under a placement with Antiviral Technologies Portfolio LLC
Nanoveu also produces EyeFly3D, which converts 2D digital displays into 3D without the need for 3D glasses and is currently available for Apple iPhones and Google Pixel 3 phones.
Nanoveu continues antiviral product development heading into 2021
The company develops a range of products for mobile phones and other digital displays with its flagship product, Nanosheild, available in a variety of mobile screen covers, phone cases and as a commercial film capable of being applied to se
Nanoveu concludes $660,000 placement to develop range of antiviral products
The placement firms up the balance sheet and ensures the company is able to fully focus on securing international distribution agreements for antiviral products, and advance development of the EyeFyx prototype.
Nanoveu placement improves company’s financial position leading into 2021
The placement firms up the balance sheet and ensures the company is able to fully focus on securing international distribution agreements for antiviral products, and advance development of the EyeFyx prototype.
Nanoveu in trading halt ahead of capital raising announcement
The trading halt will remain in place until Friday, December 11, or when an announcement is released to the market.
Nanoveu in exclusive 12-month Australian and New Zealand distribution deal with Touch Guard for its antiviral products
The agreement marks an expansion of distribution capabilities throughout Australia and a new market in New Zealand, which NVU had not previously targeted for product distribution.
Nanoveu soars with advanced EyeFyx prototype having potential to disrupt digital display industry
The latest EyeFyx prototype is aimed at improving access to digital devices for people suffering from farsightedness.
Nanoveu sees increasing global interest in antiviral product with strong sales momentum
During the September quarter, the company appointed several new distributors across many regions and secured sales orders of around $250,000 for its B2B antiviral film and antiviral mobile phone protection products.
Nanoveu shares soar as antiviral product sales accelerate across multiple geographies
Sales to Vietnam add to Nanoveu’s growing order book with customers in Australia, Malaysia, Singapore, Thailand, UK, and USA.
Nanoveu granted trading halt with sales update announcement pending
Unless ASX decides otherwise, the securities will remain halted until the start of normal trading on Thursday, September 24, or when an announcement is released to the market.
Nanoveu boosts balance sheet after landing institutional investment of up to $2.4 million
The funding will go towards commercialisation of the company’s new business lines in antiviral screen protector technology and laminating machines.
Nanoveu in back-to-back trading halts ahead of capital raising news
The company has recently signed agreements with Sanyo Trading Company Ltd for exclusive distribution of its antiviral products.
Nanoveu higher on signing Thai and Malaysian distribution agreements for antiviral protection products
The company has signed agreements with Sanyo Trading Company Ltd for exclusive distribution of its antiviral products.
Nanoveu fills first antiviral product sales orders, on track for first revenue in quarter three
The company is confident of strong demand for its products, with orders from customers across the US, UK, Asia and Australia.
Nanoveu shares up following Singapore antiviral protection distribution agreement
The agreement will expand the application of Nanoveu’s antiviral technology through the sale of antiviral gym and home fitness equipment to the Asia-Pacific region.
Nanoveu to deploy phone screen protector laminating machines in Thailand
An agreement has been signed with a subsidiary of major Thai telecommunications network AIS to deploy Customskins laminating machines.
Nanoveu in strong position for antiviral product launch following specialist sales team appointment
D360 will assist in online retail sales as well as go-to-market services for the US, Canada and UK regions
Nanoveu higher as antiviral phone protectors are approved by TGA
The Australian Therapeutics Goods Administration has registered the technology as a Class I Medical Device.
Nanoveu shares surge as antiviral technology independently validated against human coronaviruses
In just 30 minutes the number of viable or infectious coronavirus particles was reduced by 99.99%.
Nanoveu shares soar after testing validates smartphone screen antiviral technology against coronaviruses
The antimicrobial technology demonstrated to be effective against a coronavirus strain emerging from mice, which is a surrogate for human coronaviruses.
Nanoveu enhances smartphone suite with anti-viral and anti-reflective technologies
The company has developed antiviral nanotechnology to deliver enhanced protection from viruses and bacteria for smartphone and tablet users.
Nanoveu attracts interest with antiviral products for smartphones
The company’s nanotechnology is being developed to protect phone and tablet users from viruses and bacteria, including coronavirus.
Nanoveu share price doubles after commencing testing of smartphone screen protectors to fight coronaviruses
Initial testing has demonstrated Nanoveu’s technology to be effective against viruses and bacteria.